August 4, 2016—Drug manufacturers have been reporting quarterly best prices for brand-name drugs to the Centers for Medicare & Medicaid Services higher than the same drugs’ average manufacturer prices.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)